Insulin, fast-acting (human)

INSULIN_SHORT_HUMAN

No definition available.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC A10AB01

6362

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

5581

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

5581

diagram downward connector

Include endpoints None

5581

diagram downward connector
INSULIN_SHORT_HUMAN

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 5581 2757 2824
Unadjusted prevalence (%) 1.57 1.39 1.79
Mean age at first event (years) 29.53 28.00 31.03

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.06 4.10 [3.01, 5.59] 2.9e-19 839
15 years 0.02 2.97 [2.38, 3.70] 3.2e-22 389
5 years 0.00 3.44 [2.77, 4.26] 2.5e-29 134
1 year 0.00 2.34 [1.42, 3.83] 7.7e-4 17

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: INSULIN_SHORT_HUMAN – Insulin, fast-acting (human)
GWS hits:

Survival analyses between endpoints

Plot

before Insulin, fast-acting (human)
after Insulin, fast-acting (human)

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Insulin, fast-acting (human)